DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Engstrom T, Kelbaek H, Helqvist S. et al. DANAMI-2–PRIMULTI Investigators.
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial.
Lancet 2015;
386: 665-671
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.